scorpion eli lilly news - Search News

Eli Lilly in talks to acquire Scorpion Therapeutics, FT says

Seeking Alpha on MSN · 1d

Eli Lilly in talks to acquire Scorpion Therapeutics, FT says; Relay Therapeutics seesaws

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. Eli Lilly (NYSE:LLY) is expected to pay around $1 billion upfront for the privately owned Scorpion,

The Financial Times · 1d

Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers

Business Insider · 1d

Lilly in advanced talks to buy cancer biotech Scorpion for up to $2.5B, FT says

Eli Lilly (LLY) is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5B, people close to the talks

Hosted on MSN15h

Potential acquisition of Scorpion positive for Relay, says Barclays

Barclays says reports of Eli Lilly (LLY) reportedly being in talks to acquire Scorpion Therapeutics has a positive read-through to Relay ...

1d

Eli Lilly: Still Much Room To Ride The Weight-Loss Wave

Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

1d

Bernstein Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results